Outcomes of peptide receptor radionuclide therapy after progression following hepatic cytoreductive operation for neuroendocrine tumors

American Journal of Surgery · Published 2026-06-10 · DOI 10.1016/j.amjsurg.2026.117099

Authors (3)

Kaiya Kozuma, Ruby Aaron, Rodney Pommier

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kozuma, K., Aaron, R., Pommier, R. (2026). Outcomes of peptide receptor radionuclide therapy after progression following hepatic cytoreductive operation for neuroendocrine tumors. American Journal of Surgery. https://doi.org/10.1016/j.amjsurg.2026.117099

Related articles

• Raised to run faster, not to heal moral injury and the surgeon's capacity to lead · American Journal of Surgery · 2026 · Same journal
• Interpreting large-scale comparative data in cholecystectomy: Indication bias and design heterogeneity · American Journal of Surgery · 2026 · Same journal
• Patient-reported outcomes after sutured repair of primary ventral hernias with permanent versus slowly absorbable sutures: a nationwide survey- and register-based study · American Journal of Surgery · 2026 · Same journal
• Pressure points: A pilot study using the NASA-TLX tool to measure the intensity of Acute care surgery work · American Journal of Surgery · 2026 · Same journal
• Modern academic rite of manuscript submission: Passwords, portals and patience · American Journal of Surgery · 2026 · Same journal
• The question of quality in cancer care: How can we make more hospitals 5-star? · American Journal of Surgery · 2026 · Same journal
• A call for practice-based research in surgery · American Journal of Surgery · 2026 · Same journal
• Digestive robotic surgery in resource-constrained settings: A stress test of surgical systems · American Journal of Surgery · 2026 · Same journal
• Robotic versus traditional coronary artery bypass grafting (CABG): A dual-phase meta-analysis comparing human and AI-derived evidence · American Journal of Surgery · 2026 · Same journal
• Validation of a novel risk stratification model for primary aldosteronism · American Journal of Surgery · 2026 · Same journal